You just read:

Pulmatrix Receives Award from Cystic Fibrosis Foundation Therapeutics to Support Development of PUR1900 for the Treatment of Pulmonary Fungal Infections

News provided by

Pulmatrix, Inc.

Sep 05, 2017, 10:00 ET